Business
Pharming Group to participate in April investor conferences
Leiden, the Netherlands, April 7, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of April: 25th Annual Needham Virtual Healthcare Conference, April 13, 2026Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Monday, April 13 at 08:45 am ET/14:45 CET. A live webcast and replay of the presentation will be available
About this update from Pharming Group Nv
Leiden, the Netherlands, April 7, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of April: For more information about these conferences, or to schedule a one-on-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at [email protected] or your Needham or Van Lanschot Kempen representative. About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S. For more information, visit www.pharming.com and find us on LinkedIn . For further public information, contact: Investor Relations Michael Levitan, VP Investor Relations & Corporate Communications T: +1 (908) 705 1696 E: [email protected] Media Relations Global: Saskia Mehring, Corporate Communications Manager T: +31 6 28 32 60 41 E: [email protected] U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming) T: +1 (917) 882-9038 Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming) T: +31 6 53 81 64 27 Attachment